Combinatorial Screening Using Orthotopic Patient Derived Xenograft-Expanded Early Phase Cultures of Osteosarcoma Identify Novel Therapeutic Drug Combinations

Lead discovery in osteosarcoma has been hampered by the lack of new agents, limited representative clinical samples and paucity of accurate preclinical models. We developed orthotopic patient-derived xenografts (PDXs) that recapitulated the molecular, cellular and histologic features of primary tumo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Lett
Autors principals: Loh, Amos H.P., Stewart, Elizabeth, Bradley, Cori L., Chen, Xiang, Daryani, Vinay, Stewart, Clinton F., Calabrese, Christopher, Funk, Amy, Miller, Greg, Karlstrom, Asa, Krafcik, Fred, Goshorn, David R., Vogel, Peter, Bahrami, Armita, Shelat, Anang, Dyer, Michael A.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6342199/
https://ncbi.nlm.nih.gov/pubmed/30395907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2018.10.033
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars